Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA

BACKGROUND: In angioimmunoblastic T-cell lymphoma, symptoms linked to B-lymphocyte activation are common, and variable numbers of CD20(+) large B-blasts, often infected by Epstein-Barr virus, are found in tumor tissues. We postulated that the disruption of putative B-T interactions and/or depletion...

詳細記述

保存先:
書誌詳細
主要な著者: Delfau-Larue, Marie-Hélène, de Leval, Laurence, Joly, Bertrand, Plonquet, Anne, Challine, Dominique, Parrens, Marie, Delmer, Alain, Salles, Gilles, Morschhauser, Franck, Delarue, Richard, Brice, Pauline, Bouabdallah, Reda, Casasnovas, Olivier, Tilly, Hervé, Gaulard, Philippe, Haioun, Corinne
フォーマット: Artigo
言語:Inglês
出版事項: Ferrata Storti Foundation 2012
主題:
Original Articles and Brief Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487562/
https://ncbi.nlm.nih.gov/pubmed/22371178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.061507
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料